Drug Retention Time of Immunosuppressive Therapy in Behcet's Uveitis

CONCLUSION: Adalimumab's drug retention time was found to be similar to and possibly better than cDMARDs in patients with BU, who often suffer from vision-threatening disease at first presentation.PMID:38412375 | DOI:10.1080/09273948.2024.2315205

Source: Ocular Immunology and Inflammation - February 27, 2024 Category: Allergy & Immunology Authors: Donald Tran Sophie Rogers Lyndell L Lim Source Type: research